Enact Holdings, Inc. (ACT)
NASDAQFinancialsInsurance - SpecialtySnapshot 2026-09-04
$49.27-0.48%
Close 2026-09-04 · 1-day change
NASDAQFinancialsInsurance - SpecialtySnapshot 2026-09-04
Broken: Recent financial performance freshly dropped to the bottom half of its industry.
Enact Holdings grows new insurance written 30% year over year. Earnings per share are stable near $4.5 annually. The company has a strong capital base and manages risks well. Its stock trades cheap with a price-to-earnings ratio of 9.7, below peers.
Growth in new insurance could slow due to housing market risks. Profit margins might compress if credit losses rise. The company faces competition and regulatory challenges that could hurt returns.
The market prices the stock about 34% below our fair value near $69. Analysts expect modest 2% revenue growth, while we see stronger growth in new insurance written. Our view is more optimistic on growth and risk management.
Breaks if: Buyback program is canceled or materially reduced
Breaks if: EPS falls below $4.0 for FY26
New insurance written falls below $10B in any quarter after 2026-Q1
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment is characterized as a stable compounder with a focus on long-term value creation. The current thesis state is weakened due to recent performance trends, despite management's consistent execution and sector support.
The market appears to price ACT as cheap compared to its peers, reflecting an expectations gap that suggests lower growth assumptions. The valuation is justified, indicating that the current stock price does not fully reflect the company's potential.
Fundamentals are likely to remain stable in the near term, as management has shown a commitment to prudent growth and capital return. However, there is a moderate risk of missing earnings expectations, especially given recent industry trends.
The thesis hinges on the performance of sector bellwethers like FNF, FAF, and ESNT. If these companies continue to perform well, ACT could benefit from the positive momentum; conversely, any signs of weakness could negatively impact ACT's outlook.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings beat is a positive factor. However, recent financial performance dropped from the top half to the bottom half of its industry. This change indicates a weakened reason to own the stock.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, ACT's performance will depend on both its execution and the broader financial sector's health. Not investment advice.